Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

4 results about "Carnitine" patented technology

Carnitine (β-hydroxy-γ-N-trimethylaminobutyric acid, 3-hydroxy-4-N,N,N-trimethylaminobutyrate) is a quaternary ammonium compound involved in metabolism in most mammals, plants, and some bacteria. Carnitine may exist in two isomers, labeled D-carnitine and L-carnitine, which are both biologically active. At room temperature, pure carnitine is a white powder, and a water-soluble zwitterion with low toxicity. Carnitine only exists in animals as the L-enantiomer, and D-carnitine is toxic because it inhibits the activity of L-carnitine. Carnitine, derived from an amino acid, is found in nearly all organisms and animal tissue. Carnitine is the generic expression for a number of compounds that include L-carnitine, acetyl-L-carnitine, and propionyl-L-carnitine. It is most accumulated in cardiac and skeletal muscles as it accounts for 0.1% of its dry matter. It was first derived from meat extracts in 1905, therefore the name carnitine is derived from Latin "carnus" or flesh. The body synthesizes enough carnitine from lysine side chains to keep up with the needs of energy production in the body as carnitine acts as a transporter of long-chain fatty acids into the mitochondria to be oxidized and produce energy. Some individuals with genetic or medical disorders (such as preterm infants) cannot make enough, so this makes carnitine a conditionally essential nutrient for them.

Dried blood spot quality control product for neonatal screening and preparation method thereof

The invention discloses a dried blood spot quality control product for neonatal screening and a preparation method thereof. The dried blood spot quality control product comprises a filter paper carrier, the filter paper carrier is infiltrated with a blood working solution, and the blood working solution takes Chinese species blood as a matrix solution, and is formed by mixing the matrix solution and an extracting solution according to a certain proportion. The extracting solution comprises amino acid, free acyl carnitine, lysophosphatidylcholine, orotic acid and succinylacetone. The dried blood spot quality control product disclosed by the invention has good uniformity and stability, and can be used as an indoor quality control product in a neonatal screening project; and the preparation process is simple and convenient to operate.
Owner:SHANGHAI ANPEL SCI INSTR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products